In 2013, Invokana was put on the market for Type 2 Diabetes patients. Due to the reports of amputations and other associated problems causing amputations over the years, the FDA was forced to step in and require the manufacturer of Invokana, Johnson & Johnson, to make a change to the warning labels. Invokana labels were at that point required to properly warn patients of the increased risk of leg and foot amputations. Patients for the first time were warned that if they experienced pain in feet or legs, tenderness, sores, or infections, they need to seek immediate medical attention.
Due to Johnson & Johnson’s failure to properly warn patients of these risks and what signs to look for, many people underwent amputations of the toes, feet, and legs.
Now, lawsuits are being filed to hold Johnson & Johnson accountable for their actions and people are obtaining compensation for their medical bills, lost wages, and pain and suffering.